Related Experiment Video
Updated: Dec 6, 2025

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells
Published on: November 23, 2014
Tumor-Derived cGAMP Regulates Activation of the Vasculature
Marco Campisi1,2, Shriram K Sundararaman2,3, Sarah E Shelton2,4
1Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Turin, Italy.
Abstract:
Intratumoral recruitment of immune cells following innate immune activation is critical for anti-tumor immunity and involves cytosolic dsDNA sensing by the cGAS/STING pathway. We have previously shown that KRAS-LKB1 (KL) mutant lung cancer, which is resistant to PD-1 blockade, exhibits silencing of STING, impaired tumor cell production of immune chemoattractants, and T cell exclusion. Since the vasculature is also a critical gatekeeper of immune cell infiltration into tumors, we developed a novel microfluidic model to study KL tumor-vascular interactions. Notably, dsDNA priming of LKB1-reconstituted tumor cells activates the microvasculature, even when tumor cell STING is deleted. cGAS-driven extracellular export of 2'3' cGAMP by cancer cells activates STING signaling in endothelial cells and cooperates with type 1 interferon to increase vascular permeability and expression of E selectin, VCAM-1, and ICAM-1 and T cell adhesion to the endothelium. Thus, tumor cell cGAS-STING signaling not only produces T cell chemoattractants, but also primes tumor vasculature for immune cell escape.
Insights
Cancer cells lacking STING can still prime tumor vasculature for immune cell infiltration. Extracellular cGAMP from cancer cells activates endothelial STING, enhancing immune cell adhesion and tumor vascular permeability, crucial for anti-tumor immunity.
Area of Science:
- Immunology
- Cancer Biology
- Vascular Biology
Background:
- Intratumoral immune cell recruitment is vital for anti-tumor immunity, relying on cytosolic dsDNA sensing via the cGAS/STING pathway.
- KRAS-LKB1 (KL) mutant lung cancer resists PD-1 blockade due to STING silencing, reduced chemoattractant production, and T cell exclusion.
- Tumor vasculature critically regulates immune cell infiltration.
Purpose of the Study:
- To investigate KL tumor-vascular interactions using a novel microfluidic model.
- To elucidate the role of cancer cell-derived cGAS-STING signaling in priming tumor vasculature for immune cell infiltration.
Main Methods:
- Development of a microfluidic model to study interactions between KL lung cancer cells and the tumor vasculature.
- Analysis of dsDNA priming effects on LKB1-reconstituted tumor cells and microvasculature, including STING-deleted conditions.
- Assessment of extracellular 2'3' cGAMP export, endothelial STING activation, and associated vascular changes (permeability, adhesion molecule expression).
Main Results:
- dsDNA priming of LKB1-reconstituted tumor cells activates the microvasculature, irrespective of tumor cell STING deletion.
- Cancer cell cGAS-driven export of 2'3' cGAMP activates STING signaling in endothelial cells.
- This activation, along with type 1 interferon, increases vascular permeability and expression of E selectin, VCAM-1, and ICAM-1, promoting T cell adhesion.
Conclusions:
- Tumor cell cGAS-STING signaling has a dual role: producing T cell chemoattractants and priming the tumor vasculature.
- Extracellular cGAMP released by cancer cells can activate endothelial STING, facilitating immune cell infiltration.
- This pathway represents a potential therapeutic target for enhancing anti-tumor immunity in STING-deficient lung cancers.
More Related Videos
04:00A Matrigel-Based Tube Formation Assay to Assess the Vasculogenic Activity of Tumor Cells
Published on: September 7, 2011
09:42Assessing Tumor Microenvironment of Metastasis Doorway-Mediated Vascular Permeability Associated with Cancer Cell Dissemination using Intravital Imaging and Fixed Tissue Analysis
Published on: June 26, 2019
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Tumor Microenvironment
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Mechanism of Angiogenesis
Cancer